Alternative use of botulinum toxin in urology

Bibliography

• SCOTT AB: Botulinum toxin injection of eye muscles to correct strabismus. iTrans. Am. Oplithahnol Soc. i (1981) 79:734.
   PubMedGoogle Scholar
• NEUMANN M, WOLFGANG HJ, TOYKA KV: Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. iArch. Neurol i(1999) 56:914–916.
   PubMedGoogle Scholar
• VERHEYDEN J, BLITZER A, BRIN MF: Other non cosmetic uses of BOTOX. i&min. Caton. Med. Surg. i (2001) 20(2):121–126.
   Google Scholar
• •A useful review.
   Google Scholar
• LEIPPOLD T, REITZ A, SCHURCH B: Botulinum toxin as a new therapy option for voiding disorders: current state of the art. iEar. Urol. i (2003) 44:165–174.
   Google Scholar
• ••A well-constructed comprehensive review.
   Google Scholar
• SLOOP RR, COLE BA, ESCUTIN RO: Human response to botulinum toxin injection: type B compared to type A. iNeurology(1997) i 49(1):189–194.
   Google Scholar
• BARNES M: Botulinum toxin - mechanisms of action and clinical use in spasticity. iRehabil Med. i (2003) 41 (Suppl.):56–59.
   Google Scholar
• WHEELER JS Jr, WALTER JS, CHINTAM RS iet al: i Botulinum toxin injections for voiding dysfunction following iSCI.j Spinal Cord Med. i (1988) 21:227–229.
   Google Scholar
• DUCHEN LW: Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. iJ. Neurol Neurosurg. Psychiatry i (1970) 33:40.
   PubMed Web of Science ®Google Scholar
• BORODIC GE, JOSEPH M, FAY L iet al: i Botulinum toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. iHead Neck i (1990) 12:392.
   PubMed Web of Science ®Google Scholar
• LAZZERI M: New pharmaological tools.22. iUrodynamica i (2003) 13:67–73.
   Google Scholar
• NOLAN J, CHALKIADIS GA, LOW J iet al.: i Anaesthesia and pain management in cerebral palsy. iAnaesthesia i (2000) 55:32–41.23.
   Google Scholar
• SCHURCH B, HAURI D, RODIC B: Botulinum-A toxin as a treatment of detrusor-sphiincter dyssynergia: a prospective study in 24 spinal cord injury patients. iUrol. i (1996) 155:1023-1029.24.
   Google Scholar
• •Further reading.
   Google Scholar
• DESEZE M, PETIT H, GALLIEN P iet al: i Botulinum A toxin and detrusor sphincter dyssynergia: a double blind lidocaine controlled study in 13 patients with spinal cord disease. iEur. Urol. i (2002) 42:56–62.
   Google Scholar
• •Further reading.
   Google Scholar
• PHELAN MW, FRANKS M,25. SOMOGYI GT iet al.: i Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction." iUrol. i (2001) 165:1107–1110.
   Google Scholar
• •Further reading.26.
   Google Scholar
• DYKSTRA D, SIDI A, SCOTT B iet al: i Effects of botulinum toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. iUrol. i (1988) 139:919–922.•
   Google Scholar
• •Further reading.27.
   Google Scholar
• DYKSTRA D, SIDI A: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double blind study. iArch. Phys. Med. Rehabil. i (1990) 71:24–26.
   PubMed Web of Science ®Google Scholar
• GALLIEN P, ROBINEAU S, VERIN M iet al.: i Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin. iArch. Phys. Med. Rehabil. i(1998) 79:715–717.
   Google Scholar
• PLEVNIK S, JANEZ J: Maximal electrical29. stimulation for urinary incontinence: report of 98 cases. iUrology i (1979) 14(6):638–645.
   Google Scholar
• LIT WILLER SE, FROHMAN EM, ZIMMERN P: Multiple sclerosis and the30.urologist." iUrol. i (1999) 161:743–757.
   Google Scholar
• SCHURCH B, STOHRER M, KRAMER D: Botulinum A toxin for treating detrusor hyperreflaxia in spinal cord31'injured patients: a new alternative to anticholinergic drugs? Preliminary results. iUrol. i (2000) 164:692–697.
   PubMed Web of Science ®Google Scholar
• SCHULTE-BAUKLOH H, MICHAEL T, SCHOBERT J: Efficacy of botulinum A toxin in children with detrusor hyperreflexia32'due to myelomeningocele: Preliminary results. iUrology i (2002) 59(3):325–328.
   Google Scholar
• • REITZ A, STOHRER M, KRAMER G iet al.: i European Experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. iEur. Urol. i (2004) 45(4):510–515. bA b relatively large bEuropean b study.
   Google Scholar
• ELLIOT DS, BOONE TB: Recent advances in the management of the neurogenic bladder. iUrology i (2000) 56(Suppl. 6A):76–81.
   Google Scholar
• SCHURCH B, SCHMID DM, STOHRER M: Treatment of neurogenic incontinence with botulinum toxin A [correspondence]. iN Engl. J. Med. i (2000) 342(9):665.
   PubMed Web of Science ®Google Scholar
• MALL V, GLOCKER FX, FRANKENSCHMIDT A iet al.: i Treatment of neuropathic bladder using botulinum toxin A in a 1 year old child with myelomeningocele. iPaediatr. Nephrol. i(2001) 16:1161–1162.
   Google Scholar
• MARIA G, DESTITO A, LACQUANTI S: Relief by botulinum toxin of voiding dysfunction due to prostatitis. iLancet i(1998) 352:625. b• b bA b bnovel b use of botulinum toxin.
   Google Scholar
• ZERMANN DH, ISHIGOOKA M, DOGGWEILER-WIYGUL R iet al.: i Perisphincteric injection of botulinum toxin type A. A treatment option in patients with chronic prostatic pain? iEur. Urol. i (2000) 38(4)393–399.
   Google Scholar
• YOKOYAMA T, KUMON H, SMITH CP iet al: i Botulinum toxin treatment of urethral and bladder dysfunction. iActa Med. Okayama. i (2002) 56(6):271–277.
   PubMed Web of Science ®Google Scholar
• FOWLER CE BETTS CD, CHRISTMAS TJ iet al.: i Botulinum toxin in the treatment of chronic urinary retention in women. iBr: J. Urol. i (1992) 70:387–389.
   Google Scholar
• KUO H: Effect of botulinum A toxin in thetreatment of voiding dysfunction due to detrusor underactivity. iUrology i (2003) 61(3):550–554.
   Google Scholar
• MARIA G, BRISINDA G, CIVELLO IM iet al.: i Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo controlled study. iUrology i (2003) 62(2):259–264.
   Google Scholar
• BORODIC GE AND PEARCE L: New concepts in botulinum toxin therapy. iDrug Sal i (1994) 11(3):145–152. Websites
   Google Scholar
• BOYD RN, BRITTON TC, ROBINSON RO iet al.: i Transient urinary incontinence after botulinum A toxin. iLancet i b(1996) b b348:481. b
   Google Scholar
• WYNDAELE JJ, VAN DROMME SA: Muscular weakness as a side effect of botulinum toxin injection for neurogenic detrusor overactivity. iSpinal Cord i (2002) 40(11):599–600.
   PubMed Web of Science ®Google Scholar
• KUMAR V, TEMPLEMAN L, CHAPPLE CR: Recent developments in the management of detrusor overactivity. iCarr: Opin. Urol. i (2003) b13(4):285–291. b
   Google Scholar
• FOWLER CJ: Urinary retention in women. iBr: J. Urol. i (2003) 91:463–464.
   Google Scholar
• HARPER M, POPAT RB, DASGUPTA R iet al.: i A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. iBr: J. Urol. i (2003) 92(3):325–326.
   Google Scholar
• KUO H: Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. " iUrol. i (2003) 170(5):1908–1912.
   Google Scholar
• SMITH CP, FRANKS ME, MCNEIL BK iet al.: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J. Urol. (2003) 169(5):1896-1900.
   Google Scholar
• •Good scientific background.
   Google Scholar
• DYKSTRA DD, PRYOR J, GOLDISH G: Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report. iArch. Phys. Med. Rehabil. i b(2003) b84(9):1399–1400.
   Google Scholar
• DYKSTRA D, ENRIQUEZ A, VALLEY M: Treatment of overactive bladder with botulinum toxin type B: a pilot study. iInt. Urogynecol. J. Pelvic Floor Dysfunct. i (2003) 14(6):424–426.
   PubMedGoogle Scholar
• DRESSLER D: Botulinum Toxin type B: where do we stand? iEur. Neurol. i (2001) 46:113–114.
   Google Scholar
• REITZ A, SCHURCH B: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. iUrol. i b(2004) b 171:804–805.
   Google Scholar
• PISTOLESI D, SELLI B, ROSSI B iet al.: i Botulinum toxin type B for type A resistant bladder spasticity. iUrol. i (2004) 171:802–803.
   Google Scholar
• http://www.bnf.org The British National Formulary homepage. Affiliation
   Google Scholar